Mary Coleman
Investor Relations Contact presso CATALYST PHARMACEUTICALS, INC.
Posizioni attive di Mary Coleman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Investor Relations Contact | 16/08/2021 | - |
Storia della carriera di Mary Coleman
Precedenti posizioni note di Mary Coleman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| AGILE THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Investor Relations Contact | 01/01/2018 | - |
| Public Communications Contact | 01/01/2018 | - | |
| SAVIENT PHARMACEUTICALS INC | Investor Relations Contact | - | - |
| Public Communications Contact | 31/08/2010 | - |
Formazione di Mary Coleman
| Bowling Green State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Investor Relations Contact | 5 |
| Public Communications Contact | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Borsa valori
- Insiders
- Mary Coleman
- Esperienza
